Matches in Nanopublications for { ?s ?p "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_assertion description "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215347.RArMo3rb8ImZlpfIBy_WbP26u4q81op5LW-y2_66EdEQA130_provenance.
- NP1215353.RA7HVbnplLFDkE8f2azJOgcpFcIp_OkrrxyS2I64J2Cxg130_assertion description "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215353.RA7HVbnplLFDkE8f2azJOgcpFcIp_OkrrxyS2I64J2Cxg130_provenance.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion description "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.